Medtronic Plc Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Medtronic Plc on September 29, 2025. The filing details a material definitive agreement involving a new debt offering and the concurrent redemption of existing senior notes.
Key Financial Metrics and Capital Structure
- New Debt Issuance: Medtronic, Inc. issued €1.5 billion in aggregate principal amount of senior notes.
- €750 million of 2.950% Senior Notes due 2030.
- €750 million of 4.200% Senior Notes due 2045.
- Net Proceeds: Approximately €1.49 billion after underwriting discounts and estimated offering expenses.
- Debt Redemption: Medtronic Luxco redeemed €500 million of its outstanding 2.625% Senior Notes due 2025 at 100% of principal plus accrued interest.
- Use of Proceeds: Net proceeds are designated to repay Medtronic Luxco's 0.000% Senior Notes due 2025 and the 2.625% Senior Notes due 2025.
- Security Status: The new notes are general unsecured senior obligations, guaranteed by Medtronic Global Holdings S.C.A. and Medtronic Plc.
Material Changes Versus Prior Period
The filing does not provide comparative financial performance data (revenue, profit, or cash flow) as it is a transaction-specific report. The primary material change is the extension of the company's debt maturity profile, replacing maturing 2025 obligations with new debt maturing in 2030 and 2045.
Outlook, Risks, and Unusual Items
- Redemption Rights: Medtronic, Inc. retains the right to redeem the notes prior to the Par Call Date at a make-whole price. After the Par Call Date (September 15, 2030 for 2030 Notes; April 15, 2045 for 2045 Notes), notes may be redeemed at 100% of principal.
- Default Provisions: An event of default, including payment defaults or bankruptcy, allows for the acceleration of the entire principal amount.
- Listing: The new notes have been approved for listing on the New York Stock Exchange.
Investor Verification Checklist
- Verify the exact net proceeds received versus the estimated €1.49 billion in subsequent financial statements.
- Confirm the successful repayment of the 0.000% and 2.625% Senior Notes due 2025 using the new proceeds.
- Review the Sixth Supplemental Indenture (Exhibit 4.1) for specific covenants and make-whole redemption calculations.
- Monitor the impact of the new interest rates (2.950% and 4.200%) on future interest expense relative to the redeemed debt.